{"transactions":[{"id":4637645,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO CFO"}}],"security":"Restricted Stock Units","published_at":"2026-10-08T01:35:01.000Z","date":"2026-10-06","kind":"exercise","planned":false,"acquired":false,"shares":167584,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs shall vest with respect to 1/6th of the shares on July 6, 2026 and quarterly thereafter over the following ten quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs shall vest with respect to 1/6th of the shares on July 6, 2026 and quarterly thereafter over the following ten quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":1508249,"derivative":{"underlying":"Common Stock","underlying_shares":167584},"source":{"system":"sec-edgar","filing":"0001493152-26-046201","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315226046201/ownership.xml","form_type":"4"}},{"id":4637644,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO CFO"}}],"security":"Restricted Stock Units","published_at":"2026-10-08T01:35:01.000Z","date":"2026-10-06","kind":"exercise","planned":false,"acquired":false,"shares":3059800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs shall vest with respect to 1/3rd of the shares on October 6, 2026 and quarterly thereafter over the following eight quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs shall vest with respect to 1/3rd of the shares on October 6, 2026 and quarterly thereafter over the following eight quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":6119600,"derivative":{"underlying":"Common Stock","underlying_shares":3059800},"source":{"system":"sec-edgar","filing":"0001493152-26-046201","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315226046201/ownership.xml","form_type":"4"}},{"id":4637643,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO CFO"}}],"security":"Common Stock","published_at":"2026-10-08T01:35:01.000Z","date":"2026-10-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":1411982,"price":1.49,"value":2103853.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares of common stock the Issuer has withheld to satisfy the Reporting Person's income tax withholding and remittance obligations as part of the settlement of vested RSUs. Accordingly, no shares of common stock will be sold in the public market to satisfy such income tax withholding and remittance obligations associated with the settlement of these vested RSUs."}],"balance_after":1944690,"source":{"system":"sec-edgar","filing":"0001493152-26-046201","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315226046201/ownership.xml","form_type":"4"}},{"id":4637642,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO CFO"}}],"security":"Common Stock","published_at":"2026-10-08T01:35:01.000Z","date":"2026-10-06","kind":"exercise","planned":false,"acquired":true,"shares":3227384,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\")."}],"balance_after":3356672,"source":{"system":"sec-edgar","filing":"0001493152-26-046201","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315226046201/ownership.xml","form_type":"4"}},{"id":678930,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO"}}],"security":"Common Stock","published_at":"2026-08-21T22:26:55.000Z","date":"2026-08-19","kind":"gift","planned":false,"acquired":true,"shares":88400,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By FCW Investments, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person transferred these shares to FCW Investments, LLC. The Reporting Person is the managing member of FCW Investments, LLC and has the sole investment and voting power over the securities held by this entity."}],"balance_after":88451,"source":{"system":"sec-edgar","filing":"0001493152-26-039746","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315226039746/ownership.xml","form_type":"4"}},{"id":678929,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO"}}],"security":"Common Stock","published_at":"2026-08-21T22:26:55.000Z","date":"2026-08-19","kind":"gift","planned":false,"acquired":false,"shares":88400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person transferred these shares to FCW Investments, LLC. The Reporting Person is the managing member of FCW Investments, LLC and has the sole investment and voting power over the securities held by this entity."}],"balance_after":129288,"source":{"system":"sec-edgar","filing":"0001493152-26-039746","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315226039746/ownership.xml","form_type":"4"}},{"id":712728,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO"}}],"security":"Series 2 Common Stock Purchase Warrant","published_at":"2026-07-08T22:49:46.000Z","date":"2026-07-07","kind":"exercise","planned":false,"acquired":false,"shares":133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"As adjusted in accordance with the terms of the Series 2 Common Stock Purchase Warrants following the public offering that closed on October 2, 2025."},{"field":"shares","element":"transactionShares","label":"F9","text":"Reflects adjustments pursuant to the Issuer's 1-for-50 reverse stock split effective November 15, 2022, and the Issuer's 1-for-15 reverse stock split effective April 5, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Represents Series 2 Common Stock Purchase Warrants received as part of the Units purchased by Reporting Person. The Series 2 Warrants became exercisable upon receipt of stockholder approval per Nasdaq rules, which was obtained on October 6, 2022."}],"balance_after":0,"derivative":{"exercise_price":0.7,"expiration_date":"2027-08-16","underlying":"Common Stock","underlying_shares":133},"source":{"system":"sec-edgar","filing":"0001493152-26-032559","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315226032559/ownership.xml","form_type":"4"}},{"id":712727,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO"}}],"security":"Restricted Stock Units","published_at":"2026-07-08T22:49:46.000Z","date":"2026-07-06","kind":"exercise","planned":false,"acquired":false,"shares":335167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs shall vest with respect to 1/6th of the shares on July 6, 2026 and quarterly thereafter over the following 10 quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs shall vest with respect to 1/6th of the shares on July 6, 2026 and quarterly thereafter over the following 10 quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":1675833,"derivative":{"underlying":"Common Stock","underlying_shares":335167},"source":{"system":"sec-edgar","filing":"0001493152-26-032559","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315226032559/ownership.xml","form_type":"4"}},{"id":712726,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO"}}],"security":"Common Stock","published_at":"2026-07-08T22:49:46.000Z","date":"2026-07-07","kind":"exercise","planned":false,"acquired":true,"shares":133,"price":0.7,"value":93.1,"ownership":{"direct":true},"balance_after":217688,"source":{"system":"sec-edgar","filing":"0001493152-26-032559","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315226032559/ownership.xml","form_type":"4"}},{"id":712725,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO"}}],"security":"Common Stock","published_at":"2026-07-08T22:49:46.000Z","date":"2026-07-07","kind":"sale","planned":false,"acquired":false,"shares":146798,"price":2.0664,"value":303343.3872,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported in this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.045 to $2.09, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":217555,"source":{"system":"sec-edgar","filing":"0001493152-26-032559","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315226032559/ownership.xml","form_type":"4"}},{"id":712724,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO"}}],"security":"Common Stock","published_at":"2026-07-08T22:49:46.000Z","date":"2026-07-06","kind":"exercise","planned":false,"acquired":true,"shares":335167,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\") granted on February 9, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\") granted on February 9, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,899 shares acquired under the Issuer's Employee Stock Purchase Plan on May 20, 2026. In addition, the amount of securities beneficially owned was reduced by 66 shares due to an administrative error in the total reported in the Form 4 filed February 13, 2026."}],"balance_after":364353,"source":{"system":"sec-edgar","filing":"0001493152-26-032559","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315226032559/ownership.xml","form_type":"4"}},{"id":905350,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO"}}],"security":"Restricted Stock Units","published_at":"2026-02-14T01:07:40.000Z","date":"2026-02-11","kind":"exercise","planned":false,"acquired":false,"shares":13333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs shall vest in three equal annual installments beginning on February 11, 2026, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs shall vest in three equal annual installments beginning on February 11, 2026, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":26667,"derivative":{"underlying":"Common Stock","underlying_shares":13333},"source":{"system":"sec-edgar","filing":"0001493152-26-006831","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315226006831/ownership.xml","form_type":"4"}},{"id":905349,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO"}}],"security":"Common Stock","published_at":"2026-02-14T01:07:40.000Z","date":"2026-02-12","kind":"sale","planned":false,"acquired":false,"shares":3896,"price":1.75,"value":6818.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported in this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs."}],"balance_after":27353,"source":{"system":"sec-edgar","filing":"0001493152-26-006831","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315226006831/ownership.xml","form_type":"4"}},{"id":905348,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO"}}],"security":"Common Stock","published_at":"2026-02-14T01:07:40.000Z","date":"2026-02-11","kind":"exercise","planned":false,"acquired":true,"shares":13333,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\") granted on February 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\") granted on February 11, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,444 shares acquired under the Issuer's Employee Stock Purchase Plan on November 20, 2025."}],"balance_after":31249,"source":{"system":"sec-edgar","filing":"0001493152-26-006831","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315226006831/ownership.xml","form_type":"4"}},{"id":910096,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO"}}],"security":"Restricted Stock Units","published_at":"2026-02-11T22:32:05.000Z","date":"2026-02-09","kind":"grant","planned":false,"acquired":true,"shares":2011000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock, provided that, until such time as the Issuer has sufficient shares of Issuer common stock reserved under its 2021 Equity Incentive Plan to issue upon settlement of all outstanding grants thereunder, the RSUs may be settled upon vesting in cash."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vest with respect to 1/6th of the shares on July 6, 2026 and quarterly thereafter over the following 10 quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs shall vest with respect to 1/6th of the shares on July 6, 2026 and quarterly thereafter over the following 10 quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":2011000,"derivative":{"underlying":"Common Stock","underlying_shares":2011000},"source":{"system":"sec-edgar","filing":"0001493152-26-006255","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315226006255/ownership.xml","form_type":"4"}},{"id":1021582,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO"}}],"security":"Restricted Stock Units","published_at":"2025-10-08T21:39:00.000Z","date":"2025-10-06","kind":"grant","planned":false,"acquired":true,"shares":9179400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock, provided that, until such time as the Issuer has sufficient shares of Issuer common stock reserved under its 2021 Equity Incentive Plan to issue upon settlement of all outstanding grants thereunder, the RSUs may be settled upon vesting in cash."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vest with respect to 1/3rd of the shares on October 6, 2026 and quarterly thereafter over the following eight quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs shall vest with respect to 1/3rd of the shares on October 6, 2026 and quarterly thereafter over the following eight quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":9179400,"derivative":{"underlying":"Common Stock","underlying_shares":9179400},"source":{"system":"sec-edgar","filing":"0001493152-25-017475","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315225017475/ownership.xml","form_type":"4"}},{"id":1046880,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO"}}],"security":"Phantom Units","published_at":"2025-09-05T13:00:39.000Z","date":"2025-09-04","kind":"grant","planned":false,"acquired":true,"shares":323400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Phantom Unit is the economic equivalent of one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Phantom Units vest in 12 equal quarterly installments beginning on November 5, 2025, subject to the Reporting Person's continuous service through each applicable vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service by the Issuer without Cause; (b) a Liquidity Change in Control of the Issuer; or (c) 7th anniversary of the grant date, in each case as such capitalized terms are defined in the Issuer's Phantom Unit Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Phantom Units vest in 12 equal quarterly installments beginning on November 5, 2025, subject to the Reporting Person's continuous service through each applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service by the Issuer without Cause; (b) a Liquidity Change in Control of the Issuer; or (c) 7th anniversary of the grant date, in each case as such capitalized terms are defined in the Issuer's Phantom Unit Plan."}],"balance_after":323400,"derivative":{"underlying":"Common Stock","underlying_shares":323400},"source":{"system":"sec-edgar","filing":"0001493152-25-012690","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315225012690/ownership.xml","form_type":"4"}},{"id":1269747,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO"}}],"security":"Restricted Stock Units","published_at":"2025-02-13T22:56:42.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest in three equal annual installments beginning on February 11, 2026, subject to the Reporting Person's continuous service through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest in three equal annual installments beginning on February 11, 2026, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":40000,"derivative":{"underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-25-006498","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315225006498/ownership.xml","form_type":"4"}},{"id":1269746,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-13T22:56:42.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":47000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in twelve equal quarterly installments over a three-year period beginning on May 11, 2025, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":47000,"derivative":{"exercise_price":1.13,"expiration_date":"2035-02-11","underlying":"Common Stock","underlying_shares":47000},"source":{"system":"sec-edgar","filing":"0001493152-25-006498","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315225006498/ownership.xml","form_type":"4"}},{"id":1498023,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Restricted Stock Units","published_at":"2024-05-30T23:44:32.000Z","date":"2024-05-28","kind":"exercise","planned":false,"acquired":false,"shares":2111,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F11","text":"This restricted stock unit was granted on November 21, 2023, and all remaining 2,111 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F11","text":"This restricted stock unit was granted on November 21, 2023, and all remaining 2,111 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"This restricted stock unit was granted on November 21, 2023, and all remaining 2,111 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2111},"source":{"system":"sec-edgar","filing":"0001493152-24-022037","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224022037/ownership.xml","form_type":"4"}},{"id":1498022,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Restricted Stock Units","published_at":"2024-05-30T23:44:32.000Z","date":"2024-05-28","kind":"exercise","planned":false,"acquired":false,"shares":3335,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F10","text":"This restricted stock unit was granted on June 11, 2023, and all remaining 3,335 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F10","text":"This restricted stock unit was granted on June 11, 2023, and all remaining 3,335 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"This restricted stock unit was granted on June 11, 2023, and all remaining 3,335 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3335},"source":{"system":"sec-edgar","filing":"0001493152-24-022037","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224022037/ownership.xml","form_type":"4"}},{"id":1498021,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Restricted Stock Units","published_at":"2024-05-30T23:44:32.000Z","date":"2024-05-28","kind":"exercise","planned":false,"acquired":false,"shares":1622,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F9","text":"This restricted stock unit was granted on June 8, 2023, and all remaining 1,622 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"This restricted stock unit was granted on June 8, 2023, and all remaining 1,622 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This restricted stock unit was granted on June 8, 2023, and all remaining 1,622 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1622},"source":{"system":"sec-edgar","filing":"0001493152-24-022037","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224022037/ownership.xml","form_type":"4"}},{"id":1498020,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-30T23:44:32.000Z","date":"2024-05-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":607,"price":4.76,"value":2889.32,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 5."},{"field":"shares","element":"transactionShares","label":"F6","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 5."}],"balance_after":13472,"source":{"system":"sec-edgar","filing":"0001493152-24-022037","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224022037/ownership.xml","form_type":"4"}},{"id":1498019,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-30T23:44:32.000Z","date":"2024-05-28","kind":"exercise","planned":false,"acquired":true,"shares":2111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023."}],"balance_after":14079,"source":{"system":"sec-edgar","filing":"0001493152-24-022037","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224022037/ownership.xml","form_type":"4"}},{"id":1498018,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-30T23:44:32.000Z","date":"2024-05-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":959,"price":4.76,"value":4564.84,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 3."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 3."}],"balance_after":11968,"source":{"system":"sec-edgar","filing":"0001493152-24-022037","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224022037/ownership.xml","form_type":"4"}},{"id":1498017,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-30T23:44:32.000Z","date":"2024-05-28","kind":"exercise","planned":false,"acquired":true,"shares":3335,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023."}],"balance_after":12927,"source":{"system":"sec-edgar","filing":"0001493152-24-022037","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224022037/ownership.xml","form_type":"4"}},{"id":1498016,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-30T23:44:32.000Z","date":"2024-05-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":467,"price":4.76,"value":2222.92,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 1."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 1."}],"balance_after":9592,"source":{"system":"sec-edgar","filing":"0001493152-24-022037","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224022037/ownership.xml","form_type":"4"}},{"id":1498015,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-30T23:44:32.000Z","date":"2024-05-28","kind":"exercise","planned":false,"acquired":true,"shares":1622,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 8, 2023."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 8, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 8, 2023."}],"balance_after":10059,"source":{"system":"sec-edgar","filing":"0001493152-24-022037","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224022037/ownership.xml","form_type":"4"}},{"id":1500580,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-28T10:02:01.000Z","date":"2024-05-24","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":4.81,"value":4810.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reporting Person purchased 1,000 shares of Common Stock of Issuer at a price per share of $4.81 on May 24, 2024."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting Person purchased 1,000 shares of Common Stock of Issuer at a price per share of $4.81 on May 24, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 1,000 shares of Common Stock of Issuer at a price per share of $4.81 on May 24, 2024."}],"balance_after":8437,"source":{"system":"sec-edgar","filing":"0001493152-24-021431","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224021431/ownership.xml","form_type":"4"}},{"id":1505630,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-22T20:52:00.000Z","date":"2024-05-20","kind":"grant","planned":false,"acquired":true,"shares":666,"price":4.9725,"value":3311.685,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares were purchased pursuant to the Palisade Bio, Inc. 2021 Employee Stock Purchase Plan, as amended (\"ESPP\") for the ESPP purchase period from November 21, 2023 through May 20, 2024. In accordance with the ESPP, the shares were purchased in a transaction exempt under Rule 16b-3(c) at a price equal to 85% of the closing price of the issuer's common stock on May 20, 2024."},{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were purchased pursuant to the Palisade Bio, Inc. 2021 Employee Stock Purchase Plan, as amended (\"ESPP\") for the ESPP purchase period from November 21, 2023 through May 20, 2024. In accordance with the ESPP, the shares were purchased in a transaction exempt under Rule 16b-3(c) at a price equal to 85% of the closing price of the issuer's common stock on May 20, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares were purchased pursuant to the Palisade Bio, Inc. 2021 Employee Stock Purchase Plan, as amended (\"ESPP\") for the ESPP purchase period from November 21, 2023 through May 20, 2024. In accordance with the ESPP, the shares were purchased in a transaction exempt under Rule 16b-3(c) at a price equal to 85% of the closing price of the issuer's common stock on May 20, 2024."}],"balance_after":7437,"source":{"system":"sec-edgar","filing":"0001493152-24-021045","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224021045/ownership.xml","form_type":"4"}},{"id":1523438,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Restricted Stock Units","published_at":"2024-05-08T22:36:23.000Z","date":"2024-05-06","kind":"exercise","planned":false,"acquired":false,"shares":211,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F8","text":"This restricted stock unit was granted on November 21, 2023, and 211 restricted stock units subject to the award vested on May 6, 2024, and an additional 2,111 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"This restricted stock unit was granted on November 21, 2023, and 211 restricted stock units subject to the award vested on May 6, 2024, and an additional 2,111 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This restricted stock unit was granted on November 21, 2023, and 211 restricted stock units subject to the award vested on May 6, 2024, and an additional 2,111 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."}],"balance_after":2111,"derivative":{"underlying":"Common Stock","underlying_shares":211},"source":{"system":"sec-edgar","filing":"0001493152-24-018282","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224018282/ownership.xml","form_type":"4"}},{"id":1523437,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Restricted Stock Units","published_at":"2024-05-08T22:36:23.000Z","date":"2024-05-06","kind":"exercise","planned":false,"acquired":false,"shares":232,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"This restricted stock unit was granted on June 8, 2023, and 232 restricted stock units subject to the award vested on May 6, 2024, and an additional 1,622 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"This restricted stock unit was granted on June 8, 2023, and 232 restricted stock units subject to the award vested on May 6, 2024, and an additional 1,622 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This restricted stock unit was granted on June 8, 2023, and 232 restricted stock units subject to the award vested on May 6, 2024, and an additional 1,622 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."}],"balance_after":1622,"derivative":{"underlying":"Common Stock","underlying_shares":232},"source":{"system":"sec-edgar","filing":"0001493152-24-018282","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224018282/ownership.xml","form_type":"4"}},{"id":1523436,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-08T22:36:23.000Z","date":"2024-05-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":61,"price":8.46,"value":516.06,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 3."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 3."}],"balance_after":6771,"source":{"system":"sec-edgar","filing":"0001493152-24-018282","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224018282/ownership.xml","form_type":"4"}},{"id":1523435,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-08T22:36:23.000Z","date":"2024-05-06","kind":"exercise","planned":false,"acquired":true,"shares":211,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023."}],"balance_after":6832,"source":{"system":"sec-edgar","filing":"0001493152-24-018282","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224018282/ownership.xml","form_type":"4"}},{"id":1523434,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-08T22:36:23.000Z","date":"2024-05-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":67,"price":8.46,"value":566.82,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 1."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 1."}],"balance_after":6621,"source":{"system":"sec-edgar","filing":"0001493152-24-018282","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224018282/ownership.xml","form_type":"4"}},{"id":1523433,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-08T22:36:23.000Z","date":"2024-05-06","kind":"exercise","planned":false,"acquired":true,"shares":232,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 8, 2023."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 8, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 8, 2023."}],"balance_after":6688,"source":{"system":"sec-edgar","filing":"0001493152-24-018282","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224018282/ownership.xml","form_type":"4"}},{"id":1581485,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Restricted Stock Units","published_at":"2024-03-12T22:29:18.000Z","date":"2024-03-11","kind":"exercise","planned":false,"acquired":false,"shares":5558,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"This restricted stock unit was granted on June 11, 2023, and 5,558 restricted stock units subject to the award vested on March 11, 2024, and an additional 50,025 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"This restricted stock unit was granted on June 11, 2023, and 5,558 restricted stock units subject to the award vested on March 11, 2024, and an additional 50,025 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This restricted stock unit was granted on June 11, 2023, and 5,558 restricted stock units subject to the award vested on March 11, 2024, and an additional 50,025 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."}],"balance_after":50025,"derivative":{"underlying":"Common Stock","underlying_shares":5558},"source":{"system":"sec-edgar","filing":"0001493152-24-009709","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224009709/ownership.xml","form_type":"4"}},{"id":1581484,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2024-03-12T22:29:18.000Z","date":"2024-03-11","kind":"exercise","planned":false,"acquired":true,"shares":5558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023."}],"balance_after":96849,"source":{"system":"sec-edgar","filing":"0001493152-24-009709","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224009709/ownership.xml","form_type":"4"}},{"id":1653671,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Restricted Stock Units","published_at":"2024-02-08T21:37:40.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":3167,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"This restricted stock unit was granted on November 21, 2023 and 3,167 restricted stock units subject to the award vested on February 6, 2024 and an additional 34,833 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"This restricted stock unit was granted on November 21, 2023 and 3,167 restricted stock units subject to the award vested on February 6, 2024 and an additional 34,833 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This restricted stock unit was granted on November 21, 2023 and 3,167 restricted stock units subject to the award vested on February 6, 2024 and an additional 34,833 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."}],"balance_after":34833,"derivative":{"underlying":"Common Stock","underlying_shares":3167},"source":{"system":"sec-edgar","filing":"0001493152-24-005480","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224005480/ownership.xml","form_type":"4"}},{"id":1653670,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Restricted Stock Units","published_at":"2024-02-08T21:37:40.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":3475,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"This restricted stock unit was granted on February 6, 2023, and 3,475 restricted stock units subject to the award vested on February 6, 2024, and an additional 27,800 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"This restricted stock unit was granted on February 6, 2023, and 3,475 restricted stock units subject to the award vested on February 6, 2024, and an additional 27,800 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This restricted stock unit was granted on February 6, 2023, and 3,475 restricted stock units subject to the award vested on February 6, 2024, and an additional 27,800 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."}],"balance_after":27800,"derivative":{"underlying":"Common Stock","underlying_shares":3475},"source":{"system":"sec-edgar","filing":"0001493152-24-005480","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224005480/ownership.xml","form_type":"4"}},{"id":1653669,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2024-02-08T21:37:40.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":true,"shares":3167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023."}],"balance_after":91291,"source":{"system":"sec-edgar","filing":"0001493152-24-005480","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224005480/ownership.xml","form_type":"4"}},{"id":1653668,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2024-02-08T21:37:40.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":true,"shares":3475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on February 6, 2023."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on February 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on February 6, 2023."}],"balance_after":88124,"source":{"system":"sec-edgar","filing":"0001493152-24-005480","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224005480/ownership.xml","form_type":"4"}},{"id":1655440,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2024-02-07T13:30:10.000Z","date":"2024-02-06","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.4692,"value":4692.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reporting Person purchased 10,000 shares of Common Stock in open market purchase transactions ranging from $0.46 to $0.47. The Reporting Person agrees to provide full information regarding the number of shares purchased at each separate price paid if requested by the SEC Staff, the Company, or a security holder of the Company."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting Person purchased 10,000 shares of Common Stock in open market purchase transactions ranging from $0.46 to $0.47. The Reporting Person agrees to provide full information regarding the number of shares purchased at each separate price paid if requested by the SEC Staff, the Company, or a security holder of the Company."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 10,000 shares of Common Stock in open market purchase transactions ranging from $0.46 to $0.47. The Reporting Person agrees to provide full information regarding the number of shares purchased at each separate price paid if requested by the SEC Staff, the Company, or a security holder of the Company."}],"balance_after":84649,"source":{"system":"sec-edgar","filing":"0001493152-24-005207","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224005207/ownership.xml","form_type":"4"}},{"id":1664052,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2024-02-01T13:30:26.000Z","date":"2024-01-31","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.559,"value":5590.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reporting Person purchased 10,000 shares of Common Stock at a price per share of $0.559."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting Person purchased 10,000 shares of Common Stock at a price per share of $0.559."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 10,000 shares of Common Stock at a price per share of $0.559."}],"balance_after":74649,"source":{"system":"sec-edgar","filing":"0001493152-24-004566","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224004566/ownership.xml","form_type":"4"}},{"id":1685667,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Restricted Stock Units","published_at":"2024-01-05T21:00:30.000Z","date":"2024-01-03","kind":"exercise","planned":false,"acquired":false,"shares":1309,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit was granted on January 3, 2023 and 1,309 restricted stock units subject to the award vested on January 3, 2024. There are no additional restricted stock units underlying this grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit was granted on January 3, 2023 and 1,309 restricted stock units subject to the award vested on January 3, 2024. There are no additional restricted stock units underlying this grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1309},"source":{"system":"sec-edgar","filing":"0001493152-24-001394","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224001394/ownership.xml","form_type":"4"}},{"id":1685666,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2024-01-05T21:00:30.000Z","date":"2024-01-03","kind":"exercise","planned":false,"acquired":true,"shares":1309,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units."}],"balance_after":64649,"source":{"system":"sec-edgar","filing":"0001493152-24-001394","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224001394/ownership.xml","form_type":"4"}},{"id":1705069,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Restricted Stock Units","published_at":"2023-12-19T22:57:08.000Z","date":"2023-12-11","kind":"exercise","planned":false,"acquired":false,"shares":5559,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit was granted on June 11, 2023, and 5,559 restricted stock units subject to the award vested on December 11, 2023, and an additional 55,583 restricted stock units will vest in equal quarterly installments over the remaining three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit was granted on June 11, 2023, and 5,559 restricted stock units subject to the award vested on December 11, 2023, and an additional 55,583 restricted stock units will vest in equal quarterly installments over the remaining three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."}],"balance_after":55583,"derivative":{"underlying":"Common Stock","underlying_shares":5559},"source":{"system":"sec-edgar","filing":"0001493152-23-045474","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315223045474/ownership.xml","form_type":"4"}},{"id":1705068,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2023-12-19T22:57:08.000Z","date":"2023-12-11","kind":"exercise","planned":false,"acquired":true,"shares":5559,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units."}],"balance_after":63340,"source":{"system":"sec-edgar","filing":"0001493152-23-045474","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315223045474/ownership.xml","form_type":"4"}},{"id":1730398,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock Options","published_at":"2023-11-24T21:00:08.000Z","date":"2023-11-21","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"The Grants were made as discretionary grants to Reporting Person from the Issuer's 2021 Equity Incentive Plan, as amended (\"Plan\"). Pursuant to Nasdaq rules, no shares may be issued pursuant to the grants until such time as there are sufficient shares of common stock available under the Plan. The applicable vesting for each grant is subject to the Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"security","element":"securityTitle","label":"F7","text":"Each option represents the right to purchase one share of common stock at the exercise price."},{"field":"security","element":"securityTitle","label":"F8","text":"The grant vests in twelve (12) equal quarterly installments over a three (3) year period from the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The grant vests in twelve (12) equal quarterly installments over a three (3) year period from the grant date."}],"balance_after":45000,"derivative":{"exercise_price":0.59,"expiration_date":"2033-11-21","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001493152-23-042663","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315223042663/ownership.xml","form_type":"4"}},{"id":1730397,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Restricted Stock Units","published_at":"2023-11-24T21:00:08.000Z","date":"2023-11-21","kind":"grant","planned":false,"acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"The Grants were made as discretionary grants to Reporting Person from the Issuer's 2021 Equity Incentive Plan, as amended (\"Plan\"). Pursuant to Nasdaq rules, no shares may be issued pursuant to the grants until such time as there are sufficient shares of common stock available under the Plan. The applicable vesting for each grant is subject to the Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"security","element":"securityTitle","label":"F4","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"security","element":"securityTitle","label":"F5","text":"The grant vests in twelve (12) equal quarterly installments over a three (3) year period with the first vesting date to occur on February 6, 2024."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The grant vests in twelve (12) equal quarterly installments over a three (3) year period with the first vesting date to occur on February 6, 2024."},{"field":"shares","element":"transactionShares","label":"F4","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The grant vests in twelve (12) equal quarterly installments over a three (3) year period with the first vesting date to occur on February 6, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"N/A."}],"balance_after":38000,"derivative":{"underlying":"Common Stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001493152-23-042663","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315223042663/ownership.xml","form_type":"4"}},{"id":1730396,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2023-11-24T21:00:08.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0.51,"value":5100.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares were purchased pursuant to the Palisade Bio, Inc. 2021 Employee Stock Purchase Plan, as amended (\"ESPP\") for the ESPP purchase period from July 1, 2023 through November 20, 2023. In accordance with the ESPP, the shares were purchased in a transaction exempt under Rule 16b-3(c) at a price equal to 85% of the closing price of the issuer's common stock on November 20, 2023."},{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were purchased pursuant to the Palisade Bio, Inc. 2021 Employee Stock Purchase Plan, as amended (\"ESPP\") for the ESPP purchase period from July 1, 2023 through November 20, 2023. In accordance with the ESPP, the shares were purchased in a transaction exempt under Rule 16b-3(c) at a price equal to 85% of the closing price of the issuer's common stock on November 20, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares were purchased pursuant to the Palisade Bio, Inc. 2021 Employee Stock Purchase Plan, as amended (\"ESPP\") for the ESPP purchase period from July 1, 2023 through November 20, 2023. In accordance with the ESPP, the shares were purchased in a transaction exempt under Rule 16b-3(c) at a price equal to 85% of the closing price of the issuer's common stock on November 20, 2023."}],"balance_after":57781,"source":{"system":"sec-edgar","filing":"0001493152-23-042663","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315223042663/ownership.xml","form_type":"4"}},{"id":1746865,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Restricted Stock Units","published_at":"2023-11-08T22:01:03.000Z","date":"2023-11-06","kind":"exercise","planned":false,"acquired":false,"shares":3475,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit was granted on February 6, 2023, and 3,475 restricted stock units subject to the award vested on November 6, 2023, and an additional 31,275 restricted stock units will vest in equal installments over the remaining three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit was granted on February 6, 2023, and 3,475 restricted stock units subject to the award vested on November 6, 2023, and an additional 31,275 restricted stock units will vest in equal installments over the remaining three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."}],"balance_after":31275,"derivative":{"underlying":"Common Stock","underlying_shares":3475},"source":{"system":"sec-edgar","filing":"0001493152-23-039936","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315223039936/ownership.xml","form_type":"4"}},{"id":1746864,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2023-11-08T22:01:03.000Z","date":"2023-11-06","kind":"exercise","planned":false,"acquired":true,"shares":3475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units."}],"balance_after":47781,"source":{"system":"sec-edgar","filing":"0001493152-23-039936","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315223039936/ownership.xml","form_type":"4"}},{"id":1764382,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Restricted Stock Units","published_at":"2023-10-05T21:46:55.000Z","date":"2023-10-03","kind":"exercise","planned":false,"acquired":false,"shares":1309,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit was granted on January 3, 2023, and 1,309 restricted stock units subject to the award vested on October 4, 2023, and an additional 1,309 restricted stock units will vest on January 3, 2024, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit was granted on January 3, 2023, and 1,309 restricted stock units subject to the award vested on October 4, 2023, and an additional 1,309 restricted stock units will vest on January 3, 2024, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."}],"balance_after":1309,"derivative":{"underlying":"Common Stock","underlying_shares":1309},"source":{"system":"sec-edgar","filing":"0001493152-23-036404","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315223036404/ownership.xml","form_type":"4"}},{"id":1764381,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2023-10-05T21:46:55.000Z","date":"2023-10-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":397,"price":0.5501,"value":218.3897,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares sold on behalf of Reporting Person to satisfy tax requirements related to the vesting of the restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents shares sold on behalf of Reporting Person to satisfy tax requirements related to the vesting of the restricted stock units."}],"balance_after":44306,"source":{"system":"sec-edgar","filing":"0001493152-23-036404","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315223036404/ownership.xml","form_type":"4"}},{"id":1764380,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2023-10-05T21:46:55.000Z","date":"2023-10-03","kind":"exercise","planned":false,"acquired":true,"shares":1309,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":44703,"source":{"system":"sec-edgar","filing":"0001493152-23-036404","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315223036404/ownership.xml","form_type":"4"}},{"id":1771578,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2023-09-29T13:21:44.000Z","date":"2023-09-27","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":0.5392,"value":8088.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting Person purchased 15,000 shares of Common Stock of Issuer at a price per share of $0.5392 on September 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 15,000 shares of Common Stock of Issuer at a price per share of $0.5392 on September 27, 2023."}],"balance_after":43394,"source":{"system":"sec-edgar","filing":"0001493152-23-034754","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315223034754/ownership.xml","form_type":"4"}},{"id":1781123,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2023-09-14T21:00:19.000Z","date":"2023-09-13","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":0.655,"value":9825.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting Person purchased 15,000 shares of Common Stock at prices ranging from $0.636 to $0.658 with a weighted average price per share of $0.655 on September 13, 2023. The Reporting Person agrees to provide full information regarding the number of shares purchased at each separate price paid if requested by the SEC staff, the Issuer, or a security holder of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 15,000 shares of Common Stock at prices ranging from $0.636 to $0.658 with a weighted average price per share of $0.655 on September 13, 2023. The Reporting Person agrees to provide full information regarding the number of shares purchased at each separate price paid if requested by the SEC staff, the Issuer, or a security holder of the Issuer."}],"balance_after":28394,"source":{"system":"sec-edgar","filing":"0001493152-23-032655","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315223032655/ownership.xml","form_type":"4"}},{"id":1782182,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Restricted Stock Units","published_at":"2023-09-13T20:55:29.000Z","date":"2023-09-11","kind":"exercise","planned":false,"acquired":false,"shares":5558,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit was granted on June 11, 2023, and 5,558 restricted stock units subject to the award vested on September 11, 2023, and an additional 61,142 restricted stock units will vest in equal installments over the remaining three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit was granted on June 11, 2023, and 5,558 restricted stock units subject to the award vested on September 11, 2023, and an additional 61,142 restricted stock units will vest in equal installments over the remaining three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."}],"balance_after":61142,"derivative":{"underlying":"Common Stock","underlying_shares":5558},"source":{"system":"sec-edgar","filing":"0001493152-23-032505","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315223032505/ownership.xml","form_type":"4"}},{"id":1782181,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2023-09-13T20:55:29.000Z","date":"2023-09-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":1792,"price":0.655,"value":1173.76,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares sold on behalf of Reporting Person on September 11, 2023, to satisfy tax requirements related to the vesting of the restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents shares sold on behalf of Reporting Person on September 11, 2023, to satisfy tax requirements related to the vesting of the restricted stock units."}],"balance_after":13394,"source":{"system":"sec-edgar","filing":"0001493152-23-032505","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315223032505/ownership.xml","form_type":"4"}},{"id":1782180,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2023-09-13T20:55:29.000Z","date":"2023-09-11","kind":"exercise","planned":false,"acquired":true,"shares":5558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":15186,"source":{"system":"sec-edgar","filing":"0001493152-23-032505","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315223032505/ownership.xml","form_type":"4"}},{"id":1808698,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Restricted Stock Units","published_at":"2023-08-14T22:33:29.000Z","date":"2023-08-06","kind":"exercise","planned":false,"acquired":false,"shares":3475,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit was granted on February 6, 2023, and 3,475 restricted stock units subject to the award vested on August 6, 2023, and an additional 34,750 restricted stock units will vest in equal installments over the remaining three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit was granted on February 6, 2023, and 3,475 restricted stock units subject to the award vested on August 6, 2023, and an additional 34,750 restricted stock units will vest in equal installments over the remaining three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."}],"balance_after":34750,"derivative":{"underlying":"Common Stock","underlying_shares":3475},"source":{"system":"sec-edgar","filing":"0001493152-23-028702","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315223028702/ownership.xml","form_type":"4"}},{"id":1808697,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2023-08-14T22:33:29.000Z","date":"2023-08-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":1040,"price":0.7,"value":728.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares sold on behalf of Reporting Person on August 11, 2023, to satisfy tax requirements related to the vesting of the restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents shares sold on behalf of Reporting Person on August 11, 2023, to satisfy tax requirements related to the vesting of the restricted stock units."}],"balance_after":9628,"source":{"system":"sec-edgar","filing":"0001493152-23-028702","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315223028702/ownership.xml","form_type":"4"}},{"id":1808696,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2023-08-14T22:33:29.000Z","date":"2023-08-06","kind":"exercise","planned":false,"acquired":true,"shares":3475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":11057,"source":{"system":"sec-edgar","filing":"0001493152-23-028702","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315223028702/ownership.xml","form_type":"4"}},{"id":1834060,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Restricted Stock Units","published_at":"2023-07-06T22:27:18.000Z","date":"2023-07-03","kind":"exercise","planned":false,"acquired":false,"shares":1309,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit was granted on January 3, 2023, and 1,309 restricted stock units subject to the award vested on July 3, 2023, and an additional 1,309 restricted stock units will vest on each of October 3, 2023 and January 3, 2024, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit was granted on January 3, 2023, and 1,309 restricted stock units subject to the award vested on July 3, 2023, and an additional 1,309 restricted stock units will vest on each of October 3, 2023 and January 3, 2024, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."}],"balance_after":2618,"derivative":{"underlying":"Common Stock","underlying_shares":1309},"source":{"system":"sec-edgar","filing":"0001493152-23-023867","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315223023867/ownership.xml","form_type":"4"}},{"id":1834059,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2023-07-06T22:27:18.000Z","date":"2023-07-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":389,"price":1.764,"value":686.196,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares sold on behalf of Reporting Person to satisfy tax requirements related to the vesting of the restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents shares sold on behalf of Reporting Person to satisfy tax requirements related to the vesting of the restricted stock units."}],"balance_after":7193,"source":{"system":"sec-edgar","filing":"0001493152-23-023867","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315223023867/ownership.xml","form_type":"4"}},{"id":1834058,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2023-07-06T22:27:18.000Z","date":"2023-07-03","kind":"exercise","planned":false,"acquired":true,"shares":1309,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":7582,"source":{"system":"sec-edgar","filing":"0001493152-23-023867","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315223023867/ownership.xml","form_type":"4"}},{"id":1856039,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Restricted Stock Units","published_at":"2023-06-14T22:23:03.000Z","date":"2023-06-12","kind":"exercise","planned":false,"acquired":false,"shares":3475,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit was granted on February 6, 2023, and 3,475 restricted stock units subject to the award vested on June 12, 2023, upon receipt of shareholder approval of the grant, and an additional 38,225 restricted stock units will vest in equal installments over the remaining three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit was granted on February 6, 2023, and 3,475 restricted stock units subject to the award vested on June 12, 2023, upon receipt of shareholder approval of the grant, and an additional 38,225 restricted stock units will vest in equal installments over the remaining three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."}],"balance_after":38225,"derivative":{"underlying":"Common Stock","underlying_shares":3475},"source":{"system":"sec-edgar","filing":"0001493152-23-021308","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315223021308/ownership.xml","form_type":"4"}},{"id":1856038,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2023-06-14T22:23:03.000Z","date":"2023-06-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":1050,"price":1.5415,"value":1618.575,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares sold on behalf of Reporting Person to satisfy tax requirements related to the vesting of the restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents shares sold on behalf of Reporting Person to satisfy tax requirements related to the vesting of the restricted stock units."}],"balance_after":6273,"source":{"system":"sec-edgar","filing":"0001493152-23-021308","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315223021308/ownership.xml","form_type":"4"}},{"id":1856037,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2023-06-14T22:23:03.000Z","date":"2023-06-12","kind":"exercise","planned":false,"acquired":true,"shares":3475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":7323,"source":{"system":"sec-edgar","filing":"0001493152-23-021308","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315223021308/ownership.xml","form_type":"4"}},{"id":1857392,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock Options","published_at":"2023-06-13T22:43:56.000Z","date":"2023-06-11","kind":"grant","planned":false,"acquired":true,"shares":148500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Grants were made as discretionary grants to the Reporting Person, from the Issuer's 2021 Equity Incentive Plan, as amended. Each grant vests in twelve (12) equal quarterly installments over a three (3) year period from the grant date, subject to Reporting Person continuing to be a service provider at the time of vesting."},{"field":"security","element":"securityTitle","label":"F3","text":"Each option represents the right to purchase one share of common stock at the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Grants were made as discretionary grants to the Reporting Person, from the Issuer's 2021 Equity Incentive Plan, as amended. Each grant vests in twelve (12) equal quarterly installments over a three (3) year period from the grant date, subject to Reporting Person continuing to be a service provider at the time of vesting."}],"balance_after":148500,"derivative":{"exercise_price":1.6,"expiration_date":"2033-06-11","underlying":"Common Stock","underlying_shares":148500},"source":{"system":"sec-edgar","filing":"0001493152-23-021131","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315223021131/ownership.xml","form_type":"4"}},{"id":1857391,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Restricted Stock Units","published_at":"2023-06-13T22:43:56.000Z","date":"2023-06-11","kind":"grant","planned":false,"acquired":true,"shares":66700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Grants were made as discretionary grants to the Reporting Person, from the Issuer's 2021 Equity Incentive Plan, as amended. Each grant vests in twelve (12) equal quarterly installments over a three (3) year period from the grant date, subject to Reporting Person continuing to be a service provider at the time of vesting."},{"field":"security","element":"securityTitle","label":"F2","text":"Each restricted stock unit represents the right to receive one share of common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Each restricted stock unit represents the right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Grants were made as discretionary grants to the Reporting Person, from the Issuer's 2021 Equity Incentive Plan, as amended. Each grant vests in twelve (12) equal quarterly installments over a three (3) year period from the grant date, subject to Reporting Person continuing to be a service provider at the time of vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"N/A"}],"balance_after":66700,"derivative":{"underlying":"Common Stock","underlying_shares":66700},"source":{"system":"sec-edgar","filing":"0001493152-23-021131","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315223021131/ownership.xml","form_type":"4"}},{"id":1925320,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Restricted Stock Units","published_at":"2023-04-05T22:49:51.000Z","date":"2023-04-03","kind":"exercise","planned":false,"acquired":false,"shares":1309,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit was granted on January 3, 2023, and 1,309 restricted stock units subject to the award vested on April 3, 2023, and 1,309 restricted stock units are scheduled to vest on each of July 3, 2023, October 3, 2023, and January 3, 2023, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit was granted on January 3, 2023, and 1,309 restricted stock units subject to the award vested on April 3, 2023, and 1,309 restricted stock units are scheduled to vest on each of July 3, 2023, October 3, 2023, and January 3, 2023, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."}],"balance_after":3927,"derivative":{"underlying":"Common Stock","underlying_shares":1309},"source":{"system":"sec-edgar","filing":"0001493152-23-011080","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315223011080/ownership.xml","form_type":"4"}},{"id":1925319,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2023-04-05T22:49:51.000Z","date":"2023-04-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":435,"price":2.01,"value":874.35,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by Issuer to satisfy tax withholding requirements on vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents shares withheld by Issuer to satisfy tax withholding requirements on vesting of restricted stock units."}],"balance_after":3848,"source":{"system":"sec-edgar","filing":"0001493152-23-011080","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315223011080/ownership.xml","form_type":"4"}},{"id":1925318,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2023-04-05T22:49:51.000Z","date":"2023-04-03","kind":"exercise","planned":false,"acquired":true,"shares":1309,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":4283,"source":{"system":"sec-edgar","filing":"0001493152-23-011080","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315223011080/ownership.xml","form_type":"4"}},{"id":2026653,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock Purchase Option","published_at":"2023-02-09T02:01:03.000Z","date":"2023-02-06","kind":"grant","acquired":true,"shares":57200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each grant represents a one-time bonus grant to Reporting Person for services as an executive officer for the year ended December 31, 2022. The grants were issued from the Issuer's 2021 Equity Incentive Plan. Vesting for each grant is subject to: (a) the Reporting Person being a service provider to the Issuer at the time of vesting and (b) shareholder approval of the applicable grant is received."},{"field":"security","element":"securityTitle","label":"F2","text":"The applicable grant will vest: with respect to the Restricted Stock Units (\"RSUs\") and Common Stock Purchase Options (\"Options\"), in twelve (12) equal quarterly installments over a three-year period from the grant date, and with respect to the Performance Restricted Stock Units (\"PSUs\"), (i) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $3.20, and (ii) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $4.25"},{"field":"shares","element":"transactionShares","label":"F1","text":"Each grant represents a one-time bonus grant to Reporting Person for services as an executive officer for the year ended December 31, 2022. The grants were issued from the Issuer's 2021 Equity Incentive Plan. Vesting for each grant is subject to: (a) the Reporting Person being a service provider to the Issuer at the time of vesting and (b) shareholder approval of the applicable grant is received."},{"field":"shares","element":"transactionShares","label":"F2","text":"The applicable grant will vest: with respect to the Restricted Stock Units (\"RSUs\") and Common Stock Purchase Options (\"Options\"), in twelve (12) equal quarterly installments over a three-year period from the grant date, and with respect to the Performance Restricted Stock Units (\"PSUs\"), (i) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $3.20, and (ii) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $4.25"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each grant represents a one-time bonus grant to Reporting Person for services as an executive officer for the year ended December 31, 2022. The grants were issued from the Issuer's 2021 Equity Incentive Plan. Vesting for each grant is subject to: (a) the Reporting Person being a service provider to the Issuer at the time of vesting and (b) shareholder approval of the applicable grant is received."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The applicable grant will vest: with respect to the Restricted Stock Units (\"RSUs\") and Common Stock Purchase Options (\"Options\"), in twelve (12) equal quarterly installments over a three-year period from the grant date, and with respect to the Performance Restricted Stock Units (\"PSUs\"), (i) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $3.20, and (ii) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $4.25"}],"balance_after":57200,"derivative":{"exercise_price":2.4,"expiration_date":"2033-02-06","underlying":"Common Stock","underlying_shares":57200},"source":{"system":"sec-edgar","filing":"0001493152-23-003989","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315223003989/ownership.xml","form_type":"4"}},{"id":2026652,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Restricted Performance Stock Units","published_at":"2023-02-09T02:01:03.000Z","date":"2023-02-06","kind":"grant","acquired":true,"shares":32500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each grant represents a one-time bonus grant to Reporting Person for services as an executive officer for the year ended December 31, 2022. The grants were issued from the Issuer's 2021 Equity Incentive Plan. Vesting for each grant is subject to: (a) the Reporting Person being a service provider to the Issuer at the time of vesting and (b) shareholder approval of the applicable grant is received."},{"field":"security","element":"securityTitle","label":"F2","text":"The applicable grant will vest: with respect to the Restricted Stock Units (\"RSUs\") and Common Stock Purchase Options (\"Options\"), in twelve (12) equal quarterly installments over a three-year period from the grant date, and with respect to the Performance Restricted Stock Units (\"PSUs\"), (i) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $3.20, and (ii) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $4.25"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU or PSU represents a contingent right to receive one share of Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"Each grant represents a one-time bonus grant to Reporting Person for services as an executive officer for the year ended December 31, 2022. The grants were issued from the Issuer's 2021 Equity Incentive Plan. Vesting for each grant is subject to: (a) the Reporting Person being a service provider to the Issuer at the time of vesting and (b) shareholder approval of the applicable grant is received."},{"field":"shares","element":"transactionShares","label":"F3","text":"Each RSU or PSU represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each grant represents a one-time bonus grant to Reporting Person for services as an executive officer for the year ended December 31, 2022. The grants were issued from the Issuer's 2021 Equity Incentive Plan. Vesting for each grant is subject to: (a) the Reporting Person being a service provider to the Issuer at the time of vesting and (b) shareholder approval of the applicable grant is received."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The applicable grant will vest: with respect to the Restricted Stock Units (\"RSUs\") and Common Stock Purchase Options (\"Options\"), in twelve (12) equal quarterly installments over a three-year period from the grant date, and with respect to the Performance Restricted Stock Units (\"PSUs\"), (i) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $3.20, and (ii) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $4.25"}],"balance_after":32500,"derivative":{"expiration_date":"2033-02-06","underlying":"Common Stock","underlying_shares":32500},"source":{"system":"sec-edgar","filing":"0001493152-23-003989","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315223003989/ownership.xml","form_type":"4"}},{"id":2026651,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Restricted Stock Units","published_at":"2023-02-09T02:01:03.000Z","date":"2023-02-06","kind":"grant","acquired":true,"shares":41700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each grant represents a one-time bonus grant to Reporting Person for services as an executive officer for the year ended December 31, 2022. The grants were issued from the Issuer's 2021 Equity Incentive Plan. Vesting for each grant is subject to: (a) the Reporting Person being a service provider to the Issuer at the time of vesting and (b) shareholder approval of the applicable grant is received."},{"field":"security","element":"securityTitle","label":"F2","text":"The applicable grant will vest: with respect to the Restricted Stock Units (\"RSUs\") and Common Stock Purchase Options (\"Options\"), in twelve (12) equal quarterly installments over a three-year period from the grant date, and with respect to the Performance Restricted Stock Units (\"PSUs\"), (i) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $3.20, and (ii) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $4.25"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU or PSU represents a contingent right to receive one share of Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"Each grant represents a one-time bonus grant to Reporting Person for services as an executive officer for the year ended December 31, 2022. The grants were issued from the Issuer's 2021 Equity Incentive Plan. Vesting for each grant is subject to: (a) the Reporting Person being a service provider to the Issuer at the time of vesting and (b) shareholder approval of the applicable grant is received."},{"field":"shares","element":"transactionShares","label":"F3","text":"Each RSU or PSU represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each grant represents a one-time bonus grant to Reporting Person for services as an executive officer for the year ended December 31, 2022. The grants were issued from the Issuer's 2021 Equity Incentive Plan. Vesting for each grant is subject to: (a) the Reporting Person being a service provider to the Issuer at the time of vesting and (b) shareholder approval of the applicable grant is received."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The applicable grant will vest: with respect to the Restricted Stock Units (\"RSUs\") and Common Stock Purchase Options (\"Options\"), in twelve (12) equal quarterly installments over a three-year period from the grant date, and with respect to the Performance Restricted Stock Units (\"PSUs\"), (i) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $3.20, and (ii) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $4.25"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"N/A"}],"balance_after":41700,"derivative":{"underlying":"Common Stock","underlying_shares":41700},"source":{"system":"sec-edgar","filing":"0001493152-23-003989","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315223003989/ownership.xml","form_type":"4"}},{"id":2060616,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2023-01-07T00:42:07.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":5236,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents a one-time retention grant to Reporting Person valued at $20,000 on the date of grant based on the closing price of the Issuer's common stock on the date of grant. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 4/3/23, 7/3/23, 10/3/23, and 1/3/24."},{"field":"security","element":"securityTitle","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. The restricted stock units were issued from the Issuer's 2021 Equity Incentive Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. The restricted stock units were issued from the Issuer's 2021 Equity Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a one-time retention grant to Reporting Person valued at $20,000 on the date of grant based on the closing price of the Issuer's common stock on the date of grant. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 4/3/23, 7/3/23, 10/3/23, and 1/3/24."},{"field":"shares","element":"transactionShares","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. The restricted stock units were issued from the Issuer's 2021 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents a one-time retention grant to Reporting Person valued at $20,000 on the date of grant based on the closing price of the Issuer's common stock on the date of grant. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 4/3/23, 7/3/23, 10/3/23, and 1/3/24."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"N/A"}],"balance_after":5236,"derivative":{"underlying":"Common Stock","underlying_shares":5236},"source":{"system":"sec-edgar","filing":"0001493152-23-000862","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315223000862/ownership.xml","form_type":"4"}},{"id":2167753,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.01","published_at":"2022-09-02T22:21:53.000Z","date":"2022-09-01","kind":"purchase","acquired":true,"shares":19481.242,"price":0.1437,"value":2799.4544754,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 19,481.242 shares of Common Stock of Issuer at prices ranging from $0.1437 to $0.1439 with a weighted average price per share of $0.1437 on September 1 2022. The reporting person agrees to provide full information regarding the number of shares purchased at each separate price paid if requested by the SEC staff, the Issuer, or a security holder of the Issuer"}],"balance_after":148727.242,"source":{"system":"sec-edgar","filing":"0001493152-22-025023","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315222025023/ownership.xml","form_type":"4"}},{"id":2174001,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.01","published_at":"2022-08-25T21:10:09.000Z","date":"2022-08-23","kind":"purchase","acquired":true,"shares":7350,"price":0.16,"value":1176.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reporting Person purchased 7,350 shares of Common Stock of Issuer at a price per share of $0.16 on August 23, 2022."}],"balance_after":129246,"source":{"system":"sec-edgar","filing":"0001493152-22-024082","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315222024082/ownership.xml","form_type":"4"}},{"id":2179680,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Series 2 Common Stock Purchase Warrant","published_at":"2022-08-19T01:04:53.000Z","date":"2022-08-16","kind":"purchase","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents Series 2 Common Stock Purchase Warrants received as part of the Units purchased by Reporting Person. The Series 2 Warrants are exercisable upon receipt of stockholder approval per Nasdaq rules, which has not been obtained as of the date of this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents Series 2 Common Stock Purchase Warrants received as part of the Units purchased by Reporting Person. The Series 2 Warrants are exercisable upon receipt of stockholder approval per Nasdaq rules, which has not been obtained as of the date of this Form 4."}],"balance_after":100000,"derivative":{"exercise_price":0.25,"expiration_date":"2027-08-16","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-22-023510","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315222023510/ownership.xml","form_type":"4"}},{"id":2179679,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Series 1 Common Stock Purchase Warrant","published_at":"2022-08-19T01:04:53.000Z","date":"2022-08-16","kind":"purchase","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents Series 1 Common Stock Purchase Warrants received as part of the Units purchased by Reporting Person. The Series 1 Warrants are exercisable upon receipt of stockholder approval per Nasdaq rules, which has not been obtained as of the date of this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents Series 1 Common Stock Purchase Warrants received as part of the Units purchased by Reporting Person. The Series 1 Warrants are exercisable upon receipt of stockholder approval per Nasdaq rules, which has not been obtained as of the date of this Form 4."}],"balance_after":100000,"derivative":{"exercise_price":0.25,"expiration_date":"2023-08-16","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-22-023510","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315222023510/ownership.xml","form_type":"4"}},{"id":2179678,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.01","published_at":"2022-08-19T01:04:53.000Z","date":"2022-08-16","kind":"purchase","acquired":true,"shares":100000,"price":0.25,"value":25000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents common shares underlying 100,000 Units of Issuer purchased by Reporting Person (\"Units\") in Underwritten Offering with each Unit containing (i) one share of common stock, (ii) one Series 1 Warrant and (iii) One Series 2 Warrant at a price per Unit of $0.25."}],"balance_after":121896,"source":{"system":"sec-edgar","filing":"0001493152-22-023510","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315222023510/ownership.xml","form_type":"4"}},{"id":2286617,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-02T21:34:57.000Z","date":"2022-04-29","kind":"other","acquired":true,"shares":12545,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By FCW Investments LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a distribution of partnership assets (shares of Palisade Bio, Inc. common stock) made by LBS Investors LP to its partners in connection with the partnership's dissolution. No additional payment is being made by any of the partners in connection with the distribution."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a distribution of partnership assets (shares of Palisade Bio, Inc. common stock) made by LBS Investors LP to its partners in connection with the partnership's dissolution. No additional payment is being made by any of the partners in connection with the distribution."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the managing member of FCW Investments LLC and has sole investment and voting power over the securities held by this entity."}],"balance_after":38867,"source":{"system":"sec-edgar","filing":"0001209191-22-026450","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000120919122026450/doc4.xml","form_type":"4"}},{"id":2317851,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-25T12:01:40.000Z","date":"2022-03-24","kind":"purchase","acquired":true,"shares":7500,"price":1.0899,"value":8174.25,"ownership":{"direct":true},"balance_after":21896,"source":{"system":"sec-edgar","filing":"0001209191-22-021051","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000120919122021051/doc4.xml","form_type":"4"}},{"id":2382418,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-22T22:57:18.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":64800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares underlying the Stock Option shall vest and become exercisable on each three-month anniversary of the vesting commencement date and if there is no corresponding day, the last day of the month."}],"balance_after":64800,"derivative":{"exercise_price":0.95,"expiration_date":"2032-02-16","underlying":"Common Stock","underlying_shares":64800},"source":{"system":"sec-edgar","filing":"0001209191-22-011855","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000120919122011855/doc4.xml","form_type":"4"}},{"id":2404510,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-10T23:39:23.000Z","date":"2021-11-18","kind":"grant","acquired":true,"shares":178091,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares underlying the Stock Option shall vest and become exercisable on each three-month anniversary of the vesting commencement date and if there is no corresponding day, the last day of the month."}],"balance_after":178091,"derivative":{"exercise_price":2.32,"expiration_date":"2031-11-17","underlying":"Common Stock","underlying_shares":178091},"source":{"system":"sec-edgar","filing":"0001209191-22-008594","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000120919122008594/doc4.xml","form_type":"4"}},{"id":2562212,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-09-22T23:36:52.000Z","date":"2021-09-21","kind":"purchase","acquired":true,"shares":2000,"price":2.44,"value":4880.0,"ownership":{"direct":true},"balance_after":14396,"source":{"system":"sec-edgar","filing":"0001209191-21-057319","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000120919121057319/doc4.xml","form_type":"4"}},{"id":2586762,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-30T18:01:44.000Z","date":"2021-08-27","kind":"purchase","acquired":true,"shares":8400,"price":2.65,"value":22260.0,"ownership":{"direct":true},"balance_after":12396,"source":{"system":"sec-edgar","filing":"0001209191-21-053803","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000120919121053803/doc4.xml","form_type":"4"}},{"id":2586761,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-30T18:01:44.000Z","date":"2021-08-27","kind":"purchase","acquired":true,"shares":1600,"price":2.63,"value":4208.0,"ownership":{"direct":true},"balance_after":3996,"source":{"system":"sec-edgar","filing":"0001209191-21-053803","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000120919121053803/doc4.xml","form_type":"4"}},{"id":2736005,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Warrant (Right to Buy)","published_at":"2021-04-29T21:51:03.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":293,"ownership":{"direct":false,"nature":"By FCW Investments LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F28","text":"Received in the Merger in exchange for a warrant to purchase 10,787 shares of LBS common stock for $1.12 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the managing member of FCW Investments LLC and has sole investment and voting power over the securities held by this entity."}],"balance_after":293,"derivative":{"exercise_price":41.2,"exercise_date":"2019-03-08","expiration_date":"2028-06-30","underlying":"Common Stock","underlying_shares":293},"source":{"system":"sec-edgar","filing":"0001209191-21-029073","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000120919121029073/doc4.xml","form_type":"4"}},{"id":2736004,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Warrant (Right to Buy)","published_at":"2021-04-29T21:51:03.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":325,"ownership":{"direct":false,"nature":"By FCW Investments LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F27","text":"Received in the Merger in exchange for a warrant to purchase 11,994 shares of LBS common stock for $1.12 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the managing member of FCW Investments LLC and has sole investment and voting power over the securities held by this entity."}],"balance_after":325,"derivative":{"exercise_price":41.2,"exercise_date":"2018-12-31","expiration_date":"2028-12-31","underlying":"Common Stock","underlying_shares":325},"source":{"system":"sec-edgar","filing":"0001209191-21-029073","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000120919121029073/doc4.xml","form_type":"4"}},{"id":2736003,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Warrant (Right to Buy)","published_at":"2021-04-29T21:51:03.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":27,"ownership":{"direct":false,"nature":"By FCW Investments LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F26","text":"Received in the Merger in exchange for a warrant to purchase 1,000 shares of LBS common stock for $0.75 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the managing member of FCW Investments LLC and has sole investment and voting power over the securities held by this entity."}],"balance_after":27,"derivative":{"exercise_price":27.59,"exercise_date":"2018-04-16","expiration_date":"2028-04-16","underlying":"Common Stock","underlying_shares":27},"source":{"system":"sec-edgar","filing":"0001209191-21-029073","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000120919121029073/doc4.xml","form_type":"4"}},{"id":2736002,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Warrant (Right to Buy)","published_at":"2021-04-29T21:51:03.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":516,"ownership":{"direct":false,"nature":"By FCW Investments LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F25","text":"Received in the Merger in exchange for a warrant to purchase 19,000 shares of LBS common stock for $0.75 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the managing member of FCW Investments LLC and has sole investment and voting power over the securities held by this entity."}],"balance_after":516,"derivative":{"exercise_price":27.59,"exercise_date":"2018-03-20","expiration_date":"2028-03-20","underlying":"Common Stock","underlying_shares":516},"source":{"system":"sec-edgar","filing":"0001209191-21-029073","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000120919121029073/doc4.xml","form_type":"4"}},{"id":2736001,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Warrant (Right to Buy)","published_at":"2021-04-29T21:51:03.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":40,"ownership":{"direct":false,"nature":"By FCW Investments LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F24","text":"Received in the Merger in exchange for a warrant to purchase 1,500 shares of LBS common stock for $0.75 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the managing member of FCW Investments LLC and has sole investment and voting power over the securities held by this entity."}],"balance_after":40,"derivative":{"exercise_price":27.59,"exercise_date":"2018-01-01","expiration_date":"2028-01-01","underlying":"Common Stock","underlying_shares":40},"source":{"system":"sec-edgar","filing":"0001209191-21-029073","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000120919121029073/doc4.xml","form_type":"4"}},{"id":2736000,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Warrant (Right to Buy)","published_at":"2021-04-29T21:51:03.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":503,"ownership":{"direct":false,"nature":"By FCW Investments LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F23","text":"Received in the Merger in exchange for a warrant to purchase 18,500 shares of LBS common stock for $0.75 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the managing member of FCW Investments LLC and has sole investment and voting power over the securities held by this entity."}],"balance_after":503,"derivative":{"exercise_price":27.59,"exercise_date":"2017-06-14","expiration_date":"2027-06-14","underlying":"Common Stock","underlying_shares":503},"source":{"system":"sec-edgar","filing":"0001209191-21-029073","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000120919121029073/doc4.xml","form_type":"4"}},{"id":2735999,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Warrant (Right to Buy)","published_at":"2021-04-29T21:51:03.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":339,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F22","text":"Received in the Merger in exchange for a warrant to purchase 12,500 shares of LBS common stock for $0.75 per share."}],"balance_after":339,"derivative":{"exercise_price":27.59,"exercise_date":"2016-09-02","expiration_date":"2026-09-02","underlying":"Common Stock","underlying_shares":339},"source":{"system":"sec-edgar","filing":"0001209191-21-029073","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000120919121029073/doc4.xml","form_type":"4"}},{"id":2735998,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Warrant (Right to Buy)","published_at":"2021-04-29T21:51:03.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":49,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F21","text":"Received in the Merger in exchange for a warrant to purchase 1,824 shares of LBS common stock for $1.12 per share."}],"balance_after":49,"derivative":{"exercise_price":41.2,"exercise_date":"2019-03-08","expiration_date":"2028-06-30","underlying":"Common Stock","underlying_shares":49},"source":{"system":"sec-edgar","filing":"0001209191-21-029073","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000120919121029073/doc4.xml","form_type":"4"}},{"id":2735997,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Warrant (Right to Buy)","published_at":"2021-04-29T21:51:03.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":51,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F20","text":"Received in the Merger in exchange for a warrant to purchase 1,894 shares of LBS common stock for $1.12 per share."}],"balance_after":51,"derivative":{"exercise_price":41.2,"exercise_date":"2018-12-31","expiration_date":"2028-12-31","underlying":"Common Stock","underlying_shares":51},"source":{"system":"sec-edgar","filing":"0001209191-21-029073","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000120919121029073/doc4.xml","form_type":"4"}}],"next_cursor":"2021-04-29T21:51:03.000000Z,2735997"}